Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vija Skripconoka

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|January 25, 2005
Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort studyVaira Leimane, Vija Riekstina, Timothy H Holtz, et al.
Annals of Internal Medicine|May 4, 2006
Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcomeTimothy H Holtz, Maya Sternberg, Steve Kammerer, et al.
The European Respiratory Journal|September 29, 2012
Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosisVija Skripconoka, Manfred Danilovits, Lea Pehme, et al.
The New England Journal of Medicine|June 8, 2012
Delamanid for multidrug-resistant pulmonary tuberculosisMaria Tarcela Gler, Vija Skripconoka, Epifanio Sanchez-Garavito, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|January 25, 2005
Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort studyVaira Leimane, Vija Riekstina, Timothy H Holtz, et al.
Annals of Internal Medicine|May 4, 2006
Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcomeTimothy H Holtz, Maya Sternberg, Steve Kammerer, et al.
The European Respiratory Journal|September 29, 2012
Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosisVija Skripconoka, Manfred Danilovits, Lea Pehme, et al.
The New England Journal of Medicine|June 8, 2012
Delamanid for multidrug-resistant pulmonary tuberculosisMaria Tarcela Gler, Vija Skripconoka, Epifanio Sanchez-Garavito, et al.
Pageof 1